Previous studies have demonstrated that endothelial cytoskeletal rearrangements and VE-cadherin internalization led to barrier disruption [35–37], supporting our findings that CD147-high gcEVs initiate endothelial dysfunction. Here, CDH5 is linked to endothelial dysfunction.